Cargando…

Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort

SIMPLE SUMMARY: This paper presents important information for the implementation of cascade screening programs for hereditary breast and ovarian cancer (HBOC) and Lynch syndrome (LS). The study examined theory-based predictors of index cases’ intention to invite relatives to a family-based cohort, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarki, Mahesh, Ming, Chang, Aissaoui, Souria, Bürki, Nicole, Caiata-Zufferey, Maria, Erlanger, Tobias Ephraim, Graffeo-Galbiati, Rossella, Heinimann, Karl, Heinzelmann-Schwarz, Viola, Monnerat, Christian, Probst-Hensch, Nicole, Rabaglio, Manuela, Zürrer-Härdi, Ursina, Chappuis, Pierre Olivier, Katapodi, Maria C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997156/
https://www.ncbi.nlm.nih.gov/pubmed/35406409
http://dx.doi.org/10.3390/cancers14071636
_version_ 1784684641256472576
author Sarki, Mahesh
Ming, Chang
Aissaoui, Souria
Bürki, Nicole
Caiata-Zufferey, Maria
Erlanger, Tobias Ephraim
Graffeo-Galbiati, Rossella
Heinimann, Karl
Heinzelmann-Schwarz, Viola
Monnerat, Christian
Probst-Hensch, Nicole
Rabaglio, Manuela
Zürrer-Härdi, Ursina
Chappuis, Pierre Olivier
Katapodi, Maria C.
author_facet Sarki, Mahesh
Ming, Chang
Aissaoui, Souria
Bürki, Nicole
Caiata-Zufferey, Maria
Erlanger, Tobias Ephraim
Graffeo-Galbiati, Rossella
Heinimann, Karl
Heinzelmann-Schwarz, Viola
Monnerat, Christian
Probst-Hensch, Nicole
Rabaglio, Manuela
Zürrer-Härdi, Ursina
Chappuis, Pierre Olivier
Katapodi, Maria C.
author_sort Sarki, Mahesh
collection PubMed
description SIMPLE SUMMARY: This paper presents important information for the implementation of cascade screening programs for hereditary breast and ovarian cancer (HBOC) and Lynch syndrome (LS). The study examined theory-based predictors of index cases’ intention to invite relatives to a family-based cohort, rates of cascade testing among relatives, and preferences of those who carry a pathogenic variant for patient- or provider-mediated communication of testing results to untested relatives. While index cases are equally likely to invite relatives of both genders, males are more likely to not respond to the invitation, especially for HBOC. Findings have implications for tailoring cascade screening programs. ABSTRACT: Cascade screening for Tier 1 cancer genetic conditions is a significant public health intervention because it identifies untested relatives of individuals known to carry pathogenic variants associated with hereditary breast and ovarian cancer (HBOC) and Lynch syndrome (LS). The Swiss CASCADE is a family-based, open-ended cohort, including carriers of HBOC- and LS-associated pathogenic variants and their relatives. This paper describes rates of cascade screening in relatives from HBOC- and LS- harboring families, examines carriers’ preferences for communication of testing results, and describes theory-based predictors of intention to invite relatives to a cascade screening program. Information has been provided by 304 index cases and 115 relatives recruited from September 2017 to December 2021. On average, 10 relatives per index case were potentially eligible for cascade screening. Approximately 65% of respondents wanted to invite relatives to the cohort, and approximately 50% indicated a preference for patient-mediated communication of testing results, possibly with the assistance of digital technology. Intention to invite relatives was higher for first- compared to second- and third-degree relatives, but was not different between syndromes or based on relatives’ gender. The family environment and carrying pathogenic variants predicts intention to invite relatives. Information helps optimize delivery of tailored genetic services.
format Online
Article
Text
id pubmed-8997156
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89971562022-04-12 Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort Sarki, Mahesh Ming, Chang Aissaoui, Souria Bürki, Nicole Caiata-Zufferey, Maria Erlanger, Tobias Ephraim Graffeo-Galbiati, Rossella Heinimann, Karl Heinzelmann-Schwarz, Viola Monnerat, Christian Probst-Hensch, Nicole Rabaglio, Manuela Zürrer-Härdi, Ursina Chappuis, Pierre Olivier Katapodi, Maria C. Cancers (Basel) Article SIMPLE SUMMARY: This paper presents important information for the implementation of cascade screening programs for hereditary breast and ovarian cancer (HBOC) and Lynch syndrome (LS). The study examined theory-based predictors of index cases’ intention to invite relatives to a family-based cohort, rates of cascade testing among relatives, and preferences of those who carry a pathogenic variant for patient- or provider-mediated communication of testing results to untested relatives. While index cases are equally likely to invite relatives of both genders, males are more likely to not respond to the invitation, especially for HBOC. Findings have implications for tailoring cascade screening programs. ABSTRACT: Cascade screening for Tier 1 cancer genetic conditions is a significant public health intervention because it identifies untested relatives of individuals known to carry pathogenic variants associated with hereditary breast and ovarian cancer (HBOC) and Lynch syndrome (LS). The Swiss CASCADE is a family-based, open-ended cohort, including carriers of HBOC- and LS-associated pathogenic variants and their relatives. This paper describes rates of cascade screening in relatives from HBOC- and LS- harboring families, examines carriers’ preferences for communication of testing results, and describes theory-based predictors of intention to invite relatives to a cascade screening program. Information has been provided by 304 index cases and 115 relatives recruited from September 2017 to December 2021. On average, 10 relatives per index case were potentially eligible for cascade screening. Approximately 65% of respondents wanted to invite relatives to the cohort, and approximately 50% indicated a preference for patient-mediated communication of testing results, possibly with the assistance of digital technology. Intention to invite relatives was higher for first- compared to second- and third-degree relatives, but was not different between syndromes or based on relatives’ gender. The family environment and carrying pathogenic variants predicts intention to invite relatives. Information helps optimize delivery of tailored genetic services. MDPI 2022-03-23 /pmc/articles/PMC8997156/ /pubmed/35406409 http://dx.doi.org/10.3390/cancers14071636 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sarki, Mahesh
Ming, Chang
Aissaoui, Souria
Bürki, Nicole
Caiata-Zufferey, Maria
Erlanger, Tobias Ephraim
Graffeo-Galbiati, Rossella
Heinimann, Karl
Heinzelmann-Schwarz, Viola
Monnerat, Christian
Probst-Hensch, Nicole
Rabaglio, Manuela
Zürrer-Härdi, Ursina
Chappuis, Pierre Olivier
Katapodi, Maria C.
Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort
title Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort
title_full Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort
title_fullStr Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort
title_full_unstemmed Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort
title_short Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort
title_sort intention to inform relatives, rates of cascade testing, and preference for patient-mediated communication in families concerned with hereditary breast and ovarian cancer and lynch syndrome: the swiss cascade cohort
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997156/
https://www.ncbi.nlm.nih.gov/pubmed/35406409
http://dx.doi.org/10.3390/cancers14071636
work_keys_str_mv AT sarkimahesh intentiontoinformrelativesratesofcascadetestingandpreferenceforpatientmediatedcommunicationinfamiliesconcernedwithhereditarybreastandovariancancerandlynchsyndrometheswisscascadecohort
AT mingchang intentiontoinformrelativesratesofcascadetestingandpreferenceforpatientmediatedcommunicationinfamiliesconcernedwithhereditarybreastandovariancancerandlynchsyndrometheswisscascadecohort
AT aissaouisouria intentiontoinformrelativesratesofcascadetestingandpreferenceforpatientmediatedcommunicationinfamiliesconcernedwithhereditarybreastandovariancancerandlynchsyndrometheswisscascadecohort
AT burkinicole intentiontoinformrelativesratesofcascadetestingandpreferenceforpatientmediatedcommunicationinfamiliesconcernedwithhereditarybreastandovariancancerandlynchsyndrometheswisscascadecohort
AT caiatazuffereymaria intentiontoinformrelativesratesofcascadetestingandpreferenceforpatientmediatedcommunicationinfamiliesconcernedwithhereditarybreastandovariancancerandlynchsyndrometheswisscascadecohort
AT erlangertobiasephraim intentiontoinformrelativesratesofcascadetestingandpreferenceforpatientmediatedcommunicationinfamiliesconcernedwithhereditarybreastandovariancancerandlynchsyndrometheswisscascadecohort
AT graffeogalbiatirossella intentiontoinformrelativesratesofcascadetestingandpreferenceforpatientmediatedcommunicationinfamiliesconcernedwithhereditarybreastandovariancancerandlynchsyndrometheswisscascadecohort
AT heinimannkarl intentiontoinformrelativesratesofcascadetestingandpreferenceforpatientmediatedcommunicationinfamiliesconcernedwithhereditarybreastandovariancancerandlynchsyndrometheswisscascadecohort
AT heinzelmannschwarzviola intentiontoinformrelativesratesofcascadetestingandpreferenceforpatientmediatedcommunicationinfamiliesconcernedwithhereditarybreastandovariancancerandlynchsyndrometheswisscascadecohort
AT monneratchristian intentiontoinformrelativesratesofcascadetestingandpreferenceforpatientmediatedcommunicationinfamiliesconcernedwithhereditarybreastandovariancancerandlynchsyndrometheswisscascadecohort
AT probsthenschnicole intentiontoinformrelativesratesofcascadetestingandpreferenceforpatientmediatedcommunicationinfamiliesconcernedwithhereditarybreastandovariancancerandlynchsyndrometheswisscascadecohort
AT rabagliomanuela intentiontoinformrelativesratesofcascadetestingandpreferenceforpatientmediatedcommunicationinfamiliesconcernedwithhereditarybreastandovariancancerandlynchsyndrometheswisscascadecohort
AT zurrerhardiursina intentiontoinformrelativesratesofcascadetestingandpreferenceforpatientmediatedcommunicationinfamiliesconcernedwithhereditarybreastandovariancancerandlynchsyndrometheswisscascadecohort
AT chappuispierreolivier intentiontoinformrelativesratesofcascadetestingandpreferenceforpatientmediatedcommunicationinfamiliesconcernedwithhereditarybreastandovariancancerandlynchsyndrometheswisscascadecohort
AT katapodimariac intentiontoinformrelativesratesofcascadetestingandpreferenceforpatientmediatedcommunicationinfamiliesconcernedwithhereditarybreastandovariancancerandlynchsyndrometheswisscascadecohort
AT intentiontoinformrelativesratesofcascadetestingandpreferenceforpatientmediatedcommunicationinfamiliesconcernedwithhereditarybreastandovariancancerandlynchsyndrometheswisscascadecohort